In Development

Next-generation capabilities for live tissue profiling  

As clinicians, scientists, and drug developers expand what is possible with elive, our science and engineering teams are advancing the platform alongside them strengthening every result and turning a growing functional data set into intelligence that compounds with each sample we assess.

These product advancements are designed to strengthen the power, precision, and reliability of the platform as we work to transform how therapeutic decisions are made.

For more information about any of the technology in our pipeline or to receive updates on availability, contact us.

vista-branding-transparent

elive Imaging: Advanced imaging

  • 3D visualization of cytotoxic effects

  • Exceptional deep resolution, expansive field of view

  • Label-free imaging

Biopulse-transparent

elive Tumor Assessment: Malignant tissue identification

  • Microwave signal probe technology

  • Immediate malignancy confirmation

  • Spatial tumor content mapping

400x400_heatmap@2x

elive™ Data: AI-driven decision-making library

  • Largest live tissue cytokine and cell death data set

  • Unparalleled biological context

  • Data agnostic engine

If you're interested in learning about how our platform is evolving or if you'd like updates on availability, fill out the form below.

Pooja Advani
Pooja Advani,
MBBD, MD

Medical Oncologist
Breast Cancer
Mayo Clinic
David Braun
David Braun,
MD, PhD

Medical Oncologist
Kidney Cancer
Yale School of Medicine
Christian Capitini
Christian Capitini, MD
Director
UW Health | Carbone Cancer Center
Kevin Eliceiri
Kevin Eliceiri, PhD
Professor of Microscopy, Medical Imaging & AI
The University of Wisconsin-Madison
Janis_Marie_Taube
Janis Marie Taube,
MD, MSc

Pathologist
Melanoma
Johns Hopkins Medicine